Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
PUT
HDFC Bank
HDB
$119B
| $15.7M | ﹤0.01% |
430,200
+97,800
| +29% | +$3.58M |
|
2277
Travelers Companies
TRV
$77.4B
| $15.7M | ﹤0.01% |
104,962
+29,503
| +39% | +$4.58M |
|
2278
CALL
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$254M
| $15.7M | ﹤0.01% |
652,800
-162,400
| -20% | -$3.25M |
|
2279
PUT
Asana
ASAN
$2.18B
| $15.7M | ﹤0.01% |
253,100
+92,600
| +58% | +$3.57M |
|
2280
Anavex Life Sciences
AVXL
$300M
| $15.7M | ﹤0.01% |
686,016
+655,260
| +2,131% | +$9.71M |
|
2281
CALL
Children's Place
PLCE
$59.4M
| $15.7M | ﹤0.01% |
168,400
+53,700
| +47% | +$4.56M |
|
|
RBAC
2282
DELISTED
RedBall Acquisition Corp.
RBAC
| $15.6M | ﹤0.01% |
1,601,642
-536,057
| -25% | -$5.31M |
|
2283
CALL
Vanguard Energy ETF
VDE
$10.7B
| $15.6M | ﹤0.01% |
206,000
-1,600
| -0.8% | -$116K |
|
2284
PUT
Agilent Technologies
A
$43.8B
| $15.6M | ﹤0.01% |
105,500
-3,000
| -3% | -$409K |
|
2285
Synopsys
SNPS
$78.5B
| $15.6M | ﹤0.01% |
56,530
+33,618
| +147% | +$8.53M |
|
|
AHT
2286
Ashford Hospitality Trust
AHT
$21.6M
| $15.6M | ﹤0.01% |
34,173
+25,220
| +282% | +$9.14M |
|
2287
CALL
Dentsply Sirona
XRAY
$2.18B
| $15.6M | ﹤0.01% |
246,300
+198,400
| +414% | +$13.1M |
|
2288
MetLife
MET
$61.3B
| $15.6M | ﹤0.01% |
260,303
-57,750
| -18% | -$3.66M |
|
2289
PUT
Stanley Black & Decker
SWK
$15.1B
| $15.6M | ﹤0.01% |
76,000
-346,400
| -82% | -$71.8M |
|
2290
CALL
Boston Properties
BXP
$11.2B
| $15.6M | ﹤0.01% |
135,700
-56,600
| -29% | -$6.35M |
|
2291
Sarepta Therapeutics
SRPT
$2.06B
| $15.5M | ﹤0.01% |
199,831
-41,689
| -17% | -$3.16M |
|
2292
PUT
Edison International
EIX
$28.7B
| $15.5M | ﹤0.01% |
268,300
+64,200
| +31% | +$3.73M |
|
2293
PUT
Melco Resorts & Entertainment
MLCO
$2.06B
| $15.5M | ﹤0.01% |
936,000
+46,200
| +5% | +$838K |
|
2294
PUT
WD-40
WDFC
$2.91B
| $15.5M | ﹤0.01% |
60,500
+52,300
| +638% | +$13.4M |
|
2295
CALL
Tenet Healthcare
THC
$22.1B
| $15.5M | ﹤0.01% |
231,400
+72,000
| +45% | +$4.47M |
|
2296
Centene
CNC
$32.3B
| $15.5M | ﹤0.01% |
212,364
-127,341
| -37% | -$8.72M |
|
2297
CALL
iShares MSCI India ETF
INDA
$6.64B
| $15.5M | ﹤0.01% |
350,000
-171,700
| -33% | -$7.36M |
|
2298
CALL
Trane Technologies
TT
$102B
| $15.5M | ﹤0.01% |
84,100
-29,000
| -26% | -$5.17M |
|
|
2299
PUT
Anavex Life Sciences
AVXL
$300M
| $15.5M | ﹤0.01% |
676,900
+308,800
| +84% | +$4.57M |
|
2300
Canadian Solar
CSIQ
$942M
| $15.5M | ﹤0.01% |
344,762
-45,623
| -12% | -$1.87M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.